The Sec61 translocon is a therapeutic vulnerability in multiple myeloma. - Domenger A; Choisy C; Baron L; Mayau V; Perthame E; Deriano L; Arnulf B; Bories JC; Dadaglio G; Demangel C (EMBO molecular medicine, 2022)